1. Academic Validation
  2. PROTAC Compounds Targeting Androgen Receptor for Cancer Therapeutics: Prostate Cancer and Kennedy's Disease

PROTAC Compounds Targeting Androgen Receptor for Cancer Therapeutics: Prostate Cancer and Kennedy's Disease

  • ACS Med Chem Lett. 2020 May 18;11(6):1092-1093. doi: 10.1021/acsmedchemlett.0c00236.
Robert B Kargbo 1
Affiliations

Affiliation

  • 1 Usona Institute, 277 Granada Drive, San Luis Obispo, California 93401-7337, United States.
Figures